Medical Journals

Enhanced Accumulation of Phosphorylated Alpha-synuclein in Double Transgenic Mice Expressing Mutant Beta-amyloid Precursor Protein and Presenilin-1.

Authors:
  • Kurata Tomoko
  • Kawarabayashi Takeshi
  • Murakami Tetsuro
  • Miyazaki Kazunori
  • Morimoto Nobutoshi
  • Ohta Yasuyuki
  • Takehisa Yasushi
  • Nagai Makiko
  • Ikeda Masaki
  • Matsubara Etsuro
  • Westaway David
  • Hyslop Peter St George
  • Harigaya Yasuo
  • Kamiya Tatsushi
  • Shoji Mikio
  • Abe Koji

From: Department of Neurology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.

Journal of neuroscience research

  • Publish Date: Aug 2007
  • ISSN: 0360-4012
  • Volume: 85
  • Issue: 10
  • Pages: 2246-52
  • Medium: Print
  • Language: English
  • Citation (JAMA): Kurata Tomoko, Kawarabayashi Takeshi, Murakami Tetsuro, et al. Enhanced Accumulation of Phosphorylated Alpha-synuclein in Double Transgenic Mice Expressing Mutant Beta-amyloid Precursor Protein and Presenilin-1.. J. Neurosci. Res. Aug 2007;85:2246-52

Abstract

A recent report showed that the accumulation of alpha-synuclein (alpha-syn) was detected in the brains of one-third of Alzheimer’s disease and Down syndrome patients. However, the relationship between amyloid-beta protein (Abeta) and alpha-syn remains unclear. We analyzed the relation between the mutation of presenilin-1 (PS-1) and the pathological features of beta-amyloidosis and alpha-synucleinopathy. We generated doubly transgenic mice overexpressing mutant beta-amyloid precursor protein (betaAPP; Tg2576) and mutant PS-1 (PS1L286Vtg; line 198) and analyzed 19 double Tg betaAPP(+)/PS(+) mice at 5-23 months (young to old), 23 age-matched single Tg betaAPP(+)/PS(-) mice, and 11 non-Tg littermates. Immunohistochemical comparison was performed in these three groups by counting the area and the number of alpha-syn- or phosphorylated alpha-syn (palpha-syn)-positive dystrophic neurites per plaque (ASPDN, pASPDN). The acceleration of Abeta pathology was found with earlier onset and exaggerated numbers in double Tg betaAPP(+)/PS(+) compared with single Tg betaAPP(+)/PS(-) mouse brains. The accumulation of ASPDN and pASPDN was also accelerated in double Tg betaAPP(+)/PS(+) compared with single Tg betaAPP(+)/PS(-) mouse brains, especially in pASPDN. The number and area of alpha-syn and palpha-syn, and the ratio of palpha-syn positive neurites were significantly higher in double Tg betaAPP(+)/PS(+) than in single Tg betaAPP(+)/PS(-) mouse brains in middle-aged and old groups. Additional overexpression of mutant PS-1 accelerated Abeta-induced alpha-synucleinopathy and further facilitated the phosphorylation of alpha-syn, suggesting a direct association between mutant PS-1 and phosphorylation of alpha-syn.

Mesh Headings (Keywords): Amyloid beta-Protein Precursor, Amyloidosis, Animals, Brain, Cerebral Cortex, Immunohistochemistry, Mice, Mice, Transgenic, Mutation, Neurites, Phosphorylation, Presenilin-1, Time Factors, alpha-Synuclein


Check for Full Text / PubMed Unique Identifier (PMID): 17526016


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.